Environmental chemicals as substrates, inhibitors or inducers of drug transporters: implication for toxicokinetics, toxicity and pharmacokinetics

Bibliography

• Fromm MF. Importance of P-glycoprotein for drug disposition in humans. Eur J Clin Invest 2003;8(Suppl 2):6-9
   Google Scholar
• Sai Y. Biochemical and molecular pharmacological aspects of transporters as determinants of drug disposition. Drug Metab Pharmacokinet 2005;20:91-9
   PubMedGoogle Scholar
• Lee W, Kim RB. Transporters and renal drug elimination. Annu Rev Pharmacol Toxicol 2004;44:137-66
   PubMed Web of Science ®Google Scholar
• Ueno M, Nakagawa T, Wu B, Transporters in the brain endothelial barrier. Curr Med Chem 2010;17:1125-38
   PubMed Web of Science ®Google Scholar
• Murakami T, Takano M. Intestinal efflux transporters and drug absorption. Expert Opin Drug Metab Toxicol 2008;4:923-39
   PubMed Web of Science ®Google Scholar
• Pang KS, Maeng HJ, Fan J. Interplay of transporters and enzymes in drug and metabolite processing. Mol Pharm 2009;6:1734-55
   PubMed Web of Science ®Google Scholar
• Leonard GD, Polgar O, Bates SE. ABC transporters and inhibitors: new targets, new agents. Curr Opin Investig Drugs 2002;3:1652-9
   PubMedGoogle Scholar
• Tirona RG. Molecular mechanisms of drug transporter regulation. Handb Exp Pharmacol 2011;373-402
   PubMedGoogle Scholar
• DuBuske LM. The role of P-glycoprotein and organic anion-transporting polypeptides in drug interactions. Drug Saf 2005;28:789-801
   PubMed Web of Science ®Google Scholar
• Glaeser H. Importance of P-glycoprotein for drug-drug interactions. Handb Exp Pharmacol 2011;285-97
   PubMedGoogle Scholar
• Kindla J, Fromm MF, Konig J. In vitro evidence for the role of OATP and OCT uptake transporters in drug-drug interactions. Expert Opin Drug Metab Toxicol 2009;5:489-500
   PubMed Web of Science ®Google Scholar
• Giacomini KM, Huang SM, Tweedie DJ, Membrane transporters in drug development. Nat Rev Drug Discov 2010;9:215-36
   PubMed Web of Science ®Google Scholar
• Lee EJ, Lean CB, Limenta LM. Role of membrane transporters in the safety profile of drugs. Expert Opin Drug Metab Toxicol 2009;5:1369-83
   PubMed Web of Science ®Google Scholar
• Leslie EM, Deeley RG, Cole SP. Toxicological relevance of the multidrug resistance protein 1, MRP1 (ABCC1) and related transporters. Toxicology 2001;167:3-23
   PubMed Web of Science ®Google Scholar
• Klaassen CD. Xenobiotic transporters: another protective mechanism for chemicals. Int J Toxicol 2002;21:7-12
   PubMed Web of Science ®Google Scholar
• Leslie EM, Deeley RG, Cole SP. Multidrug resistance proteins: role of P-glycoprotein, MRP1, MRP2, and BCRP (ABCG2) in tissue defense. Toxicol Appl Pharmacol 2005;204:216-37
   PubMed Web of Science ®Google Scholar
• Klaassen CD, Aleksunes LM. Xenobiotic, bile acid, and cholesterol transporters: function and regulation. Pharmacol Rev 2010;62:1-96
   PubMed Web of Science ®Google Scholar
• Schrenk D, Baus PR, Ermel N, Up-regulation of transporters of the MRP family by drugs and toxins. Toxicol Lett 2001;120:51-7
   PubMed Web of Science ®Google Scholar
• Weber R, Gaus C, Tysklind M, Dioxin- and POP-contaminated sites–contemporary and future relevance and challenges: overview on background, aims and scope of the series. Environ Sci Pollut Res Int 2008;15:363-93
   PubMed Web of Science ®Google Scholar
• Abernethy DR, Destefano AJ, Cecil TL, Metal impurities in food and drugs. Pharm Res 2010;27:750-5
   PubMed Web of Science ®Google Scholar
• He L, Vasiliou K, Nebert DW. Analysis and update of the human solute carrier (SLC) gene superfamily. Hum Genomics 2009;3:195-206
   PubMedGoogle Scholar
• Ciarimboli G. Organic cation transporters. Xenobiotica 2008;38:936-71
   PubMed Web of Science ®Google Scholar
• Koepsell H, Lips K, Volk C. Polyspecific organic cation transporters: structure, function, physiological roles, and biopharmaceutical implications. Pharm Res 2007;24:1227-51
   PubMed Web of Science ®Google Scholar
• Srimaroeng C, Perry JL, Pritchard JB. Physiology, structure, and regulation of the cloned organic anion transporters. Xenobiotica 2008;38:889-935
   PubMed Web of Science ®Google Scholar
• Konig J. Uptake transporters of the human OATP family: molecular characteristics, substrates, their role in drug-drug interactions, and functional consequences of polymorphisms. Handb Exp Pharmacol 2011;201:1-28
   PubMedGoogle Scholar
• Rubio-Aliaga I, Daniel H. Peptide transporters and their roles in physiological processes and drug disposition. Xenobiotica 2008;38:1022-42
   PubMed Web of Science ®Google Scholar
• Morris ME, Felmlee MA. Overview of the proton-coupled MCT (SLC16A) family of transporters: characterization, function and role in the transport of the drug of abuse gamma-hydroxybutyric acid. AAPS J 2008;10:311-21
   PubMed Web of Science ®Google Scholar
• Pastor-Anglada M, Cano-Soldado P, Errasti-Murugarren E, Casado FJ. SLC28 genes and concentrative nucleoside transporter (CNT) proteins. Xenobiotica 2008;38:972-94
   PubMed Web of Science ®Google Scholar
• Young JD, Yao SY, Sun L, Human equilibrative nucleoside transporter (ENT) family of nucleoside and nucleobase transporter proteins. Xenobiotica 2008;38:995-1021
   PubMed Web of Science ®Google Scholar
• Yonezawa A, Inui KI. Importance of the multidrug and toxin extrusion MATE/SLC47A family to pharmacokinetics, pharmacodynamics/toxicodynamics and Pharmacogenomics. Br J Pharmacol 2011; In press
   PubMedGoogle Scholar
• Sharom FJ. ABC multidrug transporters: structure, function and role in chemoresistance. Pharmacogenomics 2008;9:105-27
   PubMed Web of Science ®Google Scholar
• Fardel O, Lecureur V, Guillouzo A. The P-glycoprotein multidrug transporter. Gen Pharmacol 1996;27:1283-91
   PubMedGoogle Scholar
• Cascorbi I. P-glycoprotein: tissue distribution, substrates, and functional consequences of genetic variations. Handb Exp Pharmacol 2011;201:261-83
   PubMedGoogle Scholar
• Lecureur V, Courtois A, Payen L, Expression and regulation of hepatic drug and bile acid transporters. Toxicology 2000;153:203-19
   PubMed Web of Science ®Google Scholar
• Haimeur A, Conseil G, Deeley RG, Cole SP. The MRP-related and BCRP/ABCG2 multidrug resistance proteins: biology, substrate specificity and regulation. Curr Drug Metab 2004;5:21-53
   PubMed Web of Science ®Google Scholar
• Jedlitschky G, Hoffmann U, Kroemer HK. Structure and function of the MRP2 (ABCC2) protein and its role in drug disposition. Expert Opin Drug Metab Toxicol 2006;2:351-66
   PubMed Web of Science ®Google Scholar
• Fardel O, Jigorel E, Le Vee M, Payen L. Physiological, pharmacological and clinical features of the multidrug resistance protein 2. Biomed Pharmacother 2005;59:104-14
   PubMed Web of Science ®Google Scholar
• Keppler D. Multidrug resistance proteins (MRPs, ABCCs): importance for pathophysiology and drug therapy. Handb Exp Pharmacol 2011;201:299-323
   PubMedGoogle Scholar
• Poguntke M, Hazai E, Fromm MF, Zolk O. Drug transport by breast cancer resistance protein. Expert Opin Drug Metab Toxicol 2010;6:1363-84
   PubMed Web of Science ®Google Scholar
• Drenou B, Fardel O, Amiot L, Fauchet R. Detection of P glycoprotein activity on normal and leukemic CD34+ cells. Leuk Res 1993;17:1031-5
   PubMed Web of Science ®Google Scholar
• van Herwaarden AE, Schinkel AH. The function of breast cancer resistance protein in epithelial barriers, stem cells and milk secretion of drugs and xenotoxins. Trends Pharmacol Sci 2006;27:10-16
   PubMed Web of Science ®Google Scholar
• Peng KC, Cluzeaud F, Bens M, Tissue and cell distribution of the multidrug resistance-associated protein (MRP) in mouse intestine and kidney. J Histochem Cytochem 1999;47:757-68
   PubMed Web of Science ®Google Scholar
• Scheffer GL, Kool M, de Haas M, Tissue distribution and induction of human multidrug resistant protein 3. Lab Invest 2002;82:193-201
   PubMed Web of Science ®Google Scholar
• Li P, Wang GJ, Robertson TA, Roberts MS. Liver transporters in hepatic drug disposition: an update. Curr Drug Metab 2009;10:482-98
   PubMed Web of Science ®Google Scholar
• Kullak-Ublick GA, Stieger B, Meier PJ. Enterohepatic bile salt transporters in normal physiology and liver disease. Gastroenterology 2004;126:322-42
   PubMed Web of Science ®Google Scholar
• Funk C. The role of hepatic transporters in drug elimination. Expert Opin Drug Metab Toxicol 2008;4:363-79
   PubMed Web of Science ®Google Scholar
• Zelcer N, van de Wetering K, Hillebrand M, Mice lacking multidrug resistance protein 3 show altered morphine pharmacokinetics and morphine-6-glucuronide antinociception. Proc Natl Acad Sci USA 2005;102:7274-9
   PubMed Web of Science ®Google Scholar
• Mennone A, Soroka CJ, Cai SY, Mrp4-/- mice have an impaired cytoprotective response in obstructive cholestasis. Hepatology 2006;43:1013-21
   PubMed Web of Science ®Google Scholar
• Rius M, Hummel-Eisenbeiss J, Hofmann AF, Keppler D. Substrate specificity of human ABCC4 (MRP4)-mediated cotransport of bile acids and reduced glutathione. Am J Physiol Gastrointest Liver Physiol 2006;290:G640-9
   Google Scholar
• Zair ZM, Eloranta JJ, Stieger B, Kullak-Ublick GA. Pharmacogenetics of OATP (SLC21/SLCO), OAT and OCT (SLC22) and PEPT (SLC15) transporters in the intestine, liver and kidney. Pharmacogenomics 2008;9:597-624
   PubMed Web of Science ®Google Scholar
• El-Sheikh AA, Masereeuw R, Russel FG. Mechanisms of renal anionic drug transport. Eur J Pharmacol 2008;585:245-55
   PubMed Web of Science ®Google Scholar
• Dutheil F, Jacob A, Dauchy S, ABC transporters and cytochromes P450 in the human central nervous system: influence on brain pharmacokinetics and contribution to neurodegenerative disorders. Expert Opin Drug Metab Toxicol 2010;6:1161-74
   PubMed Web of Science ®Google Scholar
• Shawahna R, Uchida Y, Decleves X, Transcriptomic and quantitative proteomic analysis of transporters and drug metabolizing enzymes in freshly isolated human brain microvessels. Mol Pharm 2011;8:1332-41
   PubMed Web of Science ®Google Scholar
• Nies AT, Jedlitschky G, Konig J, Expression and immunolocalization of the multidrug resistance proteins, MRP1-MRP6 (ABCC1-ABCC6), in human brain. Neuroscience 2004;129:349-60
   PubMed Web of Science ®Google Scholar
• Cisternino S, Rousselle C, Lorico A, Apparent lack of Mrp1-mediated efflux at the luminal side of mouse blood-brain barrier endothelial cells. Pharm Res 2003;20:904-9
   PubMed Web of Science ®Google Scholar
• Zhang Y, Han H, Elmquist WF, Miller DW. Expression of various multidrug resistance-associated protein (MRP) homologues in brain microvessel endothelial cells. Brain Res 2000;876:148-53
   PubMed Web of Science ®Google Scholar
• Potschka H, Fedrowitz M, Loscher W. Multidrug resistance protein MRP2 contributes to blood-brain barrier function and restricts antiepileptic drug activity. J Pharmacol Exp Ther 2003;306:124-31
   PubMed Web of Science ®Google Scholar
• Prouillac C, Lecoeur S. The role of the placenta in fetal exposure to xenobiotics: importance of membrane transporters and human models for transfer studies. Drug Metab Dispos 2010;38:1623-35
   PubMed Web of Science ®Google Scholar
• Kontaxi M, Echkardt U, Hagenbuch B, Uptake of the mycotoxin ochratoxin A in liver cells occurs via the cloned organic anion transporting polypeptide. J Pharmacol Exp Ther 1996;279:1507-13
   PubMed Web of Science ®Google Scholar
• Ose A, Kusuhara H, Endo C, Functional characterization of mouse organic anion transporting peptide 1a4 in the uptake and efflux of drugs across the blood-brain barrier. Drug Metab Dispos 2010;38:168-76
   PubMed Web of Science ®Google Scholar
• Letschert K, Faulstich H, Keller D, Keppler D. Molecular characterization and inhibition of amanitin uptake into human hepatocytes. Toxicol Sci 2006;91:140-9
   PubMed Web of Science ®Google Scholar
• Fehrenbach T, Cui Y, Faulstich H, Keppler D. Characterization of the transport of the bicyclic peptide phalloidin by human hepatic transport proteins. Naunyn Schmiedebergs Arch Pharmacol 2003;368:415-20
   PubMed Web of Science ®Google Scholar
• Meier-Abt F, Faulstich H, Hagenbuch B. Identification of phalloidin uptake systems of rat and human liver. Biochim Biophys Acta 2004;1664:64-9
   PubMed Web of Science ®Google Scholar
• Fischer WJ, Altheimer S, Cattori V, Organic anion transporting polypeptides expressed in liver and brain mediate uptake of microcystin. Toxicol Appl Pharmacol 2005;203:257-63
   PubMed Web of Science ®Google Scholar
• Lu H, Choudhuri S, Ogura K, Characterization of organic anion transporting polypeptide 1b2-null mice: essential role in hepatic uptake/toxicity of phalloidin and microcystin-LR. Toxicol Sci 2008;103:35-45
   PubMed Web of Science ®Google Scholar
• Feurstein D, Kleinteich J, Heussner AH, Investigation of microcystin congener-dependent uptake into primary murine neurons. Environ Health Perspect 2010;118:1370-5
   PubMed Web of Science ®Google Scholar
• Lu WJ, Tamai I, Nezu J, Organic anion transporting polypeptide-C mediates arsenic uptake in HEK-293 cells. J Biomed Sci 2006;13:525-33
   PubMed Web of Science ®Google Scholar
• Yang CH, Glover KP, Han X. Organic anion transporting polypeptide (Oatp) 1a1-mediated perfluorooctanoate transport and evidence for a renal reabsorption mechanism of Oatp1a1 in renal elimination of perfluorocarboxylates in rats. Toxicol Lett 2009;190:163-71
   PubMed Web of Science ®Google Scholar
• Ueo H, Motohashi H, Katsura T, Inui K. Human organic anion transporter hOAT3 is a potent transporter of cephalosporin antibiotics, in comparison with hOAT1. Biochem Pharmacol 2005;70:1104-13
   PubMed Web of Science ®Google Scholar
• Cha SH, Sekine T, Fukushima JI, Identification and characterization of human organic anion transporter 3 expressing predominantly in the kidney. Mol Pharmacol 2001;59:1277-86
   PubMed Web of Science ®Google Scholar
• Cha SH, Sekine T, Kusuhara H, Molecular cloning and characterization of multispecific organic anion transporter 4 expressed in the placenta. J Biol Chem 2000;275:4507-12
   PubMed Web of Science ®Google Scholar
• Tachampa K, Takeda M, Khamdang S, Interactions of organic anion transporters and organic cation transporters with mycotoxins. J Pharmacol Sci 2008;106:435-43
   PubMed Web of Science ®Google Scholar
• Nakagawa H, Hirata T, Terada T, Roles of organic anion transporters in the renal excretion of perfluorooctanoic acid. Basic Clin Pharmacol Toxicol 2008;103:1-8
   PubMed Web of Science ®Google Scholar
• Yang CH, Glover KP, Han X. Characterization of cellular uptake of perfluorooctanoate via organic anion-transporting polypeptide 1A2, organic anion transporter 4, and urate transporter 1 for their potential roles in mediating human renal reabsorption of perfluorocarboxylates. Toxicol Sci 2010;117:294-302
   PubMed Web of Science ®Google Scholar
• Bakhiya N, Arlt VM, Bahn A, Molecular evidence for an involvement of organic anion transporters (OATs) in aristolochic acid nephropathy. Toxicology 2009;264:74-9
   PubMed Web of Science ®Google Scholar
• Chen Y, Zhang S, Sorani M, Giacomini KM. Transport of paraquat by human organic cation transporters and multidrug and toxic compound extrusion family. J Pharmacol Exp Ther 2007;322:695-700
   PubMed Web of Science ®Google Scholar
• Videmann B, Tep J, Cavret S, Lecoeur S. Epithelial transport of deoxynivalenol: involvement of human P-glycoprotein (ABCB1) and multidrug resistance-associated protein 2 (ABCC2). Food Chem Toxicol 2007;45:1938-47
   PubMed Web of Science ®Google Scholar
• Tep J, Videmann B, Mazallon M, Transepithelial transport of fusariotoxin nivalenol: mediation of secretion by ABC transporters. Toxicol Lett 2007;170:248-58
   PubMed Web of Science ®Google Scholar
• Dornetshuber R, Heffeter P, Sulyok M, Interactions between ABC-transport proteins and the secondary Fusarium metabolites enniatin and beauvericin. Mol Nutr Food Res 2009;53:904-20
   PubMed Web of Science ®Google Scholar
• De Angelis I, Frigge G, Raimondi F, Absorption of fumonisin B1 and aminopentol on an in vitro model of intestinal epithelium; the role of P-glycoprotein. Toxicon 2005;45:285-91
   PubMed Web of Science ®Google Scholar
• van Herwaarden AE, Jonker JW, Wagenaar E, The breast cancer resistance protein (Bcrp1/Abcg2) restricts exposure to the dietary carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine. Cancer Res 2003;63:6447-52
   PubMed Web of Science ®Google Scholar
• Liu J, Liu Y, Powell DA, Multidrug-resistance mdr1a/1b double knockout mice are more sensitive than wild type mice to acute arsenic toxicity, with higher arsenic accumulation in tissues. Toxicology 2002;170:55-62
   PubMed Web of Science ®Google Scholar
• Allen JD, Brinkhuis RF, van Deemter L, Extensive contribution of the multidrug transporters P-glycoprotein and Mrp1 to basal drug resistance. Cancer Res 2000;60:5761-6
   PubMed Web of Science ®Google Scholar
• Salerno M, Petroutsa M, Garnier-Suillerot A. The MRP1-mediated effluxes of arsenic and antimony do not require arsenic-glutathione and antimony-glutathione complex formation. J Bioenerg Biomembr 2002;34:135-45
   PubMed Web of Science ®Google Scholar
• Endo T, Kimura O, Sakata M. Effects of P-glycoprotein inhibitors on cadmium accumulation in cultured renal epithelial cells, LLC-PK1, and OK. Toxicol Appl Pharmacol 2002;185:166-71
   PubMed Web of Science ®Google Scholar
• Bain LJ, LeBlanc GA. Interaction of structurally diverse pesticides with the human MDR1 gene product P-glycoprotein. Toxicol Appl Pharmacol 1996;141:288-98
   PubMed Web of Science ®Google Scholar
• Schinkel AH, Smit JJ, van Tellingen O, Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs. Cell 1994;77:491-502
   PubMed Web of Science ®Google Scholar
• Lecoeur S, Videmann B, Mazallon M. Effect of organophosphate pesticide diazinon on expression and activity of intestinal P-glycoprotein. Toxicol Lett 2006;161:200-9
   PubMed Web of Science ®Google Scholar
• Loe DW, Stewart RK, Massey TE, ATP-dependent transport of aflatoxin B1 and its glutathione conjugates by the product of the multidrug resistance protein (MRP) gene. Mol Pharmacol 1997;51:1034-41
   PubMed Web of Science ®Google Scholar
• Leslie EM, Ito K, Upadhyaya P, Transport of the beta -O-glucuronide conjugate of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) by the multidrug resistance protein 1 (MRP1). Requirement for glutathione or a non-sulfur-containing analog. J Biol Chem 2001;276:27846-54
   PubMed Web of Science ®Google Scholar
• Tribull TE, Bruner RH, Bain LJ. The multidrug resistance-associated protein 1 transports methoxychlor and protects the seminiferous epithelium from injury. Toxicol Lett 2003;142:61-70
   PubMed Web of Science ®Google Scholar
• Oosterhuis B, Vukman K, Vagi E, Specific interactions of chloroacetanilide herbicides with human ABC transporter proteins. Toxicology 2008;248:45-51
   PubMed Web of Science ®Google Scholar
• Vernhet L, Courtois A, Allain N, Overexpression of the multidrug resistance-associated protein (MRP1) in human heavy metal-selected tumor cells. FEBS Lett 1999;443:321-5
   PubMed Web of Science ®Google Scholar
• Vernhet L, Allain N, Bardiau C, Differential sensitivities of MRP1-overexpressing lung tumor cells to cytotoxic metals. Toxicology 2000;142:127-34
   PubMed Web of Science ®Google Scholar
• Vernhet L, Allain N, Payen L, Resistance of human multidrug resistance-associated protein 1-overexpressing lung tumor cells to the anticancer drug arsenic trioxide. Biochem Pharmacol 2001;61:1387-91
   PubMed Web of Science ®Google Scholar
• Leslie EM, Haimeur A, Waalkes MP. Arsenic transport by the human multidrug resistance protein 1 (MRP1/ABCC1). Evidence that a tri-glutathione conjugate is required. J Biol Chem 2004;279:32700-8
   PubMed Web of Science ®Google Scholar
• Carew MW, Leslie EM. Selenium-dependent and -independent transport of arsenic by the human multidrug resistance protein 2 (MRP2/ABCC2): implications for the mutual detoxification of arsenic and selenium. Carcinogenesis 2010;31:1450-5
   PubMed Web of Science ®Google Scholar
• Kala SV, Neely MW, Kala G, The MRP2/cMOAT transporter and arsenic-glutathione complex formation are required for biliary excretion of arsenic. J Biol Chem 2000;275:33404-8
   PubMed Web of Science ®Google Scholar
• Dijkstra M, Havinga R, Vonk RJ, Kuipers F. Bile secretion of cadmium, silver, zinc and copper in the rat. Involvement of various transport systems. Life Sci 1996;59:1237-46
   PubMed Web of Science ®Google Scholar
• Tsirulnikov K, Abuladze N, Koag MC, Transport of N-acetyl-S-(1,2-dichlorovinyl)-L-cysteine, a metabolite of trichloroethylene, by mouse multidrug resistance associated protein 2 (Mrp2). Toxicol Appl Pharmacol 2010;244:218-25
   PubMed Web of Science ®Google Scholar
• Lohitnavy M, Lu Y, Lohitnavy O, A possible role of multidrug resistance-associated protein 2 (Mrp2) in hepatic excretion of PCB126, an environmental contaminant: PBPK/PD modeling. Toxicol Sci 2008;104:27-39
   PubMed Web of Science ®Google Scholar
• Schrickx J, Lektarau Y, Fink-Gremmels J. Ochratoxin A secretion by ATP-dependent membrane transporters in Caco-2 cells. Arch Toxicol 2006;80:243-9
   PubMed Web of Science ®Google Scholar
• Jonker JW, Buitelaar M, Wagenaar E, The breast cancer resistance protein protects against a major chlorophyll-derived dietary phototoxin and protoporphyria. Proc Natl Acad Sci USA 2002;99:15649-54
   PubMed Web of Science ®Google Scholar
• van Herwaarden AE, Wagenaar E, Karnekamp B, Breast cancer resistance protein (Bcrp1/Abcg2) reduces systemic exposure of the dietary carcinogens aflatoxin B1, IQ and Trp-P-1 but also mediates their secretion into breast milk. Carcinogenesis 2006;27:123-30
   PubMed Web of Science ®Google Scholar
• Ebert B, Seidel A, Lampen A. Identification of BCRP as transporter of benzo[a]pyrene conjugates metabolically formed in Caco-2 cells and its induction by Ah-receptor agonists. Carcinogenesis 2005;26:1754-63
   PubMed Web of Science ®Google Scholar
• Zedeck MS. Polycyclic aromatic hydrocarbons: a review. J Environ Pathol Toxicol 1980;3:537-67
   PubMed Web of Science ®Google Scholar
• Sreeramulu K, Liu R, Sharom FJ. Interaction of insecticides with mammalian P-glycoprotein and their effect on its transport function. Biochim Biophys Acta 2007;1768:1750-7
   PubMed Web of Science ®Google Scholar
• Pivcevic B, Zaja R. Pesticides and their binary combinations as P-glycoprotein inhibitors in NIH 3T3/MDR1 cells. Environ Toxicol Pharmacol 2006;22:268-76
   PubMed Web of Science ®Google Scholar
• Bain LJ, McLachlan JB, LeBlanc GA. Structure-activity relationships for xenobiotic transport substrates and inhibitory ligands of P-glycoprotein. Environ Health Perspect 1997;105:812-18
   PubMed Web of Science ®Google Scholar
• Shabbir A, DiStasio S, Zhao J, Differential effects of the organochlorine pesticide DDT and its metabolite p,p'-DDE on p-glycoprotein activity and expression. Toxicol Appl Pharmacol 2005;203:91-8
   PubMed Web of Science ®Google Scholar
• Iwakiri T, Okumura M, Matsunaga N, Hepatocyte growth factor increases uptake of estradiol 17beta-D-glucuronide and Oatp1 protein level in rat hepatocytes. Eur J Pharmacol 2008;580:19-26
   PubMed Web of Science ®Google Scholar
• Jani M, Makai I, Kis E, Ivermectin interacts with human ABCG2. J Pharm Sci 2011;100:94-7
   PubMed Web of Science ®Google Scholar
• Teo S, Vore M. Mirex exposure inhibits the uptake of estradiol-17 beta(beta-D-glucuronide), taurocholate, and L-alanine into isolated rat hepatocytes. Toxicol Appl Pharmacol 1990;104:411-20
   PubMed Web of Science ®Google Scholar
• Klaassen CD, Slitt AL. Regulation of hepatic transporters by xenobiotic receptors. Curr Drug Metab 2005;6:309-28
   PubMed Web of Science ®Google Scholar
• Kohle C, Bock KW. Coordinate regulation of human drug-metabolizing enzymes, and conjugate transporters by the Ah receptor, pregnane X receptor and constitutive androstane receptor. Biochem Pharmacol 2009;77:689-99
   PubMed Web of Science ®Google Scholar
• Fardel O, Payen L, Courtois A, Regulation of biliary drug efflux pump expression by hormones and xenobiotics. Toxicology 2001;167:37-46
   PubMed Web of Science ®Google Scholar
• Hankinson O. The aryl hydrocarbon receptor complex. Annu Rev Pharmacol Toxicol 1995;35:307-40
   PubMed Web of Science ®Google Scholar
• Tan KP, Wang B, Yang M, Aryl hydrocarbon receptor is a transcriptional activator of the human breast cancer resistance protein (BCRP/ABCG2). Mol Pharmacol 2010;78:175-85
   PubMed Web of Science ®Google Scholar
• van Grevenynghe J, Sparfel L, Le Vee M, Cytochrome P450-dependent toxicity of environmental polycyclic aromatic hydrocarbons towards human macrophages. Biochem Biophys Res Commun 2004;317:708-16
   PubMed Web of Science ®Google Scholar
• Xu S, Weerachayaphorn J, Cai SY, Aryl hydrocarbon receptor and NF-E2-related factor 2 are key regulators of human MRP4 expression. Am J Physiol Gastrointest Liver Physiol 2010;299:G126-35
   PubMed Web of Science ®Google Scholar
• Fardel O, Lecureur V, Corlu A, Guillouzo A. P-glycoprotein induction in rat liver epithelial cells in response to acute 3-methylcholanthrene treatment. Biochem Pharmacol 1996;51:1427-36
   PubMed Web of Science ®Google Scholar
• Mathieu MC, Lapierre I, Brault K, Raymond M. Aromatic hydrocarbon receptor (AhR).AhR nuclear translocator- and p53-mediated induction of the murine multidrug resistance mdr1 gene by 3-methylcholanthrene and benzo(a)pyrene in hepatoma cells. J Biol Chem 2001;276:4819-27
   PubMed Web of Science ®Google Scholar
• Wang X, Hawkins BT, Miller DS. Aryl hydrocarbon receptor-mediated up-regulation of ATP-driven xenobiotic efflux transporters at the blood-brain barrier. FASEB J 2011;25:644-52
   PubMed Web of Science ®Google Scholar
• Schuetz EG, Schuetz JD, Thompson MT, Phenotypic variability in induction of P-glycoprotein mRNA by aromatic hydrocarbons in primary human hepatocytes. Mol Carcinog 1995;12:61-5
   PubMed Web of Science ®Google Scholar
• Jigorel E, Le Vee M, Boursier-Neyret C, Differential regulation of sinusoidal and canalicular hepatic drug transporter expression by xenobiotics activating drug-sensing receptors in primary human hepatocytes. Drug Metab Dispos 2006;34:1756-63
   PubMed Web of Science ®Google Scholar
• Maher JM, Cheng X, Slitt AL, Induction of the multidrug resistance-associated protein family of transporters by chemical activators of receptor-mediated pathways in mouse liver. Drug Metab Dispos 2005;33:956-62
   PubMed Web of Science ®Google Scholar
• Ma X, Idle JR, Gonzalez FJ. The pregnane X receptor: from bench to bedside. Expert Opin Drug Metab Toxicol 2008;4:895-908
   PubMed Web of Science ®Google Scholar
• Tirona RG, Leake BF, Wolkoff AW, Kim RB. Human organic anion transporting polypeptide-C (SLC21A6) is a major determinant of rifampin-mediated pregnane X receptor activation. J Pharmacol Exp Ther 2003;304:223-8
   PubMed Web of Science ®Google Scholar
• Lemaire G, Mnif W, Pascussi JM, Identification of new human pregnane X receptor ligands among pesticides using a stable reporter cell system. Toxicol Sci 2006;91:501-9
   PubMed Web of Science ®Google Scholar
• Kiyosawa N, Kwekel JC, Burgoon LD, o,p'-DDT elicits PXR/CAR-, not ER-, mediated responses in the immature ovariectomized rat liver. Toxicol Sci 2008;101:350-63
   PubMed Web of Science ®Google Scholar
• Ratajewski M, Walczak-Drzewiecka A, Salkowska A, Dastych J. Aflatoxins upregulate CYP3A4 mRNA expression in a process that involves the PXR transcription factor. Toxicol Lett2011;205:146-53
   PubMed Web of Science ®Google Scholar
• Sparfel L, Payen L, Gilot D, Pregnane X receptor-dependent and -independent effects of 2-acetylaminofluorene on cytochrome P450 3A23 expression and liver cell proliferation. Biochem Biophys Res Commun 2003;300:278-84
   PubMed Web of Science ®Google Scholar
• Lecureur V, Guillouzo A, Fardel O. Differential regulation of mdr genes in response to 2-acetylaminofluorene treatment in cultured rat and human hepatocytes. Carcinogenesis 1996;17:1157-60
   PubMed Web of Science ®Google Scholar
• Courtois A, Payen L, Le Ferrec E, Differential regulation of multidrug resistance-associated protein 2 (MRP2) and cytochromes P450 2B1/2 and 3A1/2 in phenobarbital-treated hepatocytes. Biochem Pharmacol 2002;63:333-41
   PubMed Web of Science ®Google Scholar
• Cherrington NJ, Hartley DP, Li N, Organ distribution of multidrug resistance proteins 1, 2, and 3 (Mrp1, 2, and 3) mRNA and hepatic induction of Mrp3 by constitutive androstane receptor activators in rats. J Pharmacol Exp Ther 2002;300:97-104
   PubMed Web of Science ®Google Scholar
• Wang X, Sykes DB, Miller DS. Constitutive androstane receptor-mediated up-regulation of ATP-driven xenobiotic efflux transporters at the blood-brain barrier. Mol Pharmacol 2010;78:376-83
   PubMed Web of Science ®Google Scholar
• Baldwin WS, Roling JA. A concentration addition model for the activation of the constitutive androstane receptor by xenobiotic mixtures. Toxicol Sci 2009;107:93-105
   PubMed Web of Science ®Google Scholar
• Agarwala S, Chen W, Cook TJ. Effect of chlorpyrifos on efflux transporter gene expression and function in Caco-2 cells. Toxicol In Vitro 2004;18:403-9
   PubMed Web of Science ®Google Scholar
• Johnson DR, Klaassen CD. Regulation of rat multidrug resistance protein 2 by classes of prototypical microsomal enzyme inducers that activate distinct transcription pathways. Toxicol Sci 2002;67:182-9
   PubMed Web of Science ®Google Scholar
• Cheng X, Maher J, Dieter MZ, Klaassen CD. Regulation of mouse organic anion-transporting polypeptides (Oatps) in liver by prototypical microsomal enzyme inducers that activate distinct transcription factor pathways. Drug Metab Dispos 2005;33:1276-82
   PubMed Web of Science ®Google Scholar
• Wielandt AM, Vollrath V, Manzano M, Induction of the multispecific organic anion transporter (cMoat/mrp2) gene and biliary glutathione secretion by the herbicide 2,4,5-trichlorophenoxyacetic acid in the mouse liver. Biochem J 1999;341(Pt 1):105-11
   PubMedGoogle Scholar
• Kaspar JW, Niture SK, Jaiswal AK. Nrf2:INrf2 (Keap1) signaling in oxidative stress. Free Radic Biol Med 2009;47:1304-9
   PubMed Web of Science ®Google Scholar
• Cheng Q, Taguchi K, Aleksunes LM, Constitutive activation of nuclear factor-E2-related factor 2 induces biotransformation enzyme and transporter expression in livers of mice with hepatocyte-specific deletion of Kelch-like ECH-associated protein 1. J Biochem Mol Toxicol 2011;25:320-9
   PubMed Web of Science ®Google Scholar
• Singh A, Wu H, Zhang P, Expression of ABCG2 (BCRP) is regulated by Nrf2 in cancer cells that confers side population and chemoresistance phenotype. Mol Cancer Ther 2010;9:2365-76
   PubMed Web of Science ®Google Scholar
• Shen G, Kong AN. Nrf2 plays an important role in coordinated regulation of Phase II drug metabolism enzymes and Phase III drug transporters. Biopharm Drug Dispos 2009;30:345-55
   PubMed Web of Science ®Google Scholar
• Gan N, Sun X, Song L. Activation of Nrf2 by microcystin-LR provides advantages for liver cancer cell growth. Chem Res Toxicol 2010;23:1477-84
   PubMed Web of Science ®Google Scholar
• Li HY, Wu SY, Shi N. Transcription factor Nrf2 activation by deltamethrin in PC12 cells: Involvement of ROS. Toxicol Lett 2007;171:87-98
   PubMed Web of Science ®Google Scholar
• Vernhet L, Seite MP, Allain N, Arsenic induces expression of the multidrug resistance-associated protein 2 (MRP2) gene in primary rat and human hepatocytes. J Pharmacol Exp Ther 2001;298:234-9
   PubMed Web of Science ®Google Scholar
• Pi J, Qu W, Reece JM, Transcription factor Nrf2 activation by inorganic arsenic in cultured keratinocytes: involvement of hydrogen peroxide. Exp Cell Res 2003;290:234-45
   PubMed Web of Science ®Google Scholar
• Chin KV, Tanaka S, Darlington G, Heat shock and arsenite increase expression of the multidrug resistance (MDR1) gene in human renal carcinoma cells. J Biol Chem 1990;265:221-6
   PubMed Web of Science ®Google Scholar
• Thevenod F, Friedmann JM, Katsen AD, Hauser IA. Up-regulation of multidrug resistance P-glycoprotein via nuclear factor-kappaB activation protects kidney proximal tubule cells from cadmium- and reactive oxygen species-induced apoptosis. J Biol Chem 2000;275:1887-96
   PubMed Web of Science ®Google Scholar
• Maher JM, Aleksunes LM, Dieter MZ, Nrf2- and PPAR alpha-mediated regulation of hepatic Mrp transporters after exposure to perfluorooctanoic acid and perfluorodecanoic acid. Toxicol Sci 2008;106:319-28
   PubMed Web of Science ®Google Scholar
• Zlender V, Breljak D, Ljubojevic M, Low doses of ochratoxin A upregulate the protein expression of organic anion transporters Oat1, Oat2, Oat3 and Oat5 in rat kidney cortex. Toxicol Appl Pharmacol 2009;239:284-96
   PubMed Web of Science ®Google Scholar
• Habibollahi P, Ghahremani MH, Azizi E, Ostad SN. Multi drug resistance-1 (MDR1) expression in response to chronic diazinon exposure: an in vitro study on Caco-2 cells. Bull Environ Contam Toxicol 2011;86:105-9
   PubMed Web of Science ®Google Scholar
• Lorico A, Bertola A, Baum C, Role of the Multidrug Resistance Protein 1 in protection from heavy metal oxyanions: investigations in vitro and in MRP1-deficient mice. Biochem Biophys Res Commun 2002;291:617-22
   PubMed Web of Science ®Google Scholar
• Andersen V, Ostergaard M, Christensen J, Polymorphisms in the xenobiotic transporter Multidrug Resistance 1 (MDR1) and interaction with meat intake in relation to risk of colorectal cancer in a Danish prospective case-cohort study. BMC Cancer 2009;9:407
   PubMed Web of Science ®Google Scholar
• Zschiedrich K, Konig IR, Bruggemann N, MDR1 variants and risk of Parkinson disease. Association with pesticide exposure? J Neurol 2009;256:115-20
   PubMed Web of Science ®Google Scholar
• Brunette DM, Katz M. The interactions of benzo(a)pyrene with cell membranes: uptake into Chinese hamster ovary (CHO) cells and fluorescence studies with isolated membranes. Chem Biol Interact 1975;11:1-14
   PubMed Web of Science ®Google Scholar
• Sugano K, Kansy M, Artursson P, Coexistence of passive and carrier-mediated processes in drug transport. Nat Rev Drug Discov 2010;9:597-614
   PubMed Web of Science ®Google Scholar
• Gilroy DJ, Carpenter HM, Curtis LR. Chlordecone pretreatment alters [14C]chlordecone and [14C]cholesterol transport kinetics in the perfused rat liver. Fundam Appl Toxicol 1994;22:286-92
   PubMedGoogle Scholar
• Myllynen P, Kummu M, Kangas T, ABCG2/BCRP decreases the transfer of a food-born chemical carcinogen, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in perfused term human placenta. Toxicol Appl Pharmacol 2008;232:210-17
   PubMed Web of Science ®Google Scholar
• Jonker JW, Merino G, Musters S, The breast cancer resistance protein BCRP (ABCG2) concentrates drugs and carcinogenic xenotoxins into milk. Nat Med 2005;11:127-9
   PubMed Web of Science ®Google Scholar
• Elliott A, Adams J, Al-Hajj M. The ABCs of cancer stem cell drug resistance. IDrugs 2010;13:632-5
   PubMed Web of Science ®Google Scholar
• Funk C, Ponelle C, Scheuermann G, Pantze M. Cholestatic potential of troglitazone as a possible factor contributing to troglitazone-induced hepatotoxicity: in vivo and in vitro interaction at the canalicular bile salt export pump (Bsep) in the rat. Mol Pharmacol 2001;59:627-35
   PubMed Web of Science ®Google Scholar
• Jansen J, Friesema EC, Milici C, Visser TJ. Thyroid hormone transporters in health and disease. Thyroid 2005;15:757-68
   PubMed Web of Science ®Google Scholar
• Blokzijl H, van Steenpaal A, Vander Borght S, Up-regulation and cytoprotective role of epithelial multidrug resistance-associated protein 1 in inflammatory bowel disease. J Biol Chem 2008;283:35630-7
   PubMed Web of Science ®Google Scholar
• Beedholm-Ebsen R, van de Wetering K, Hardlei T, Identification of multidrug resistance protein 1 (MRP1/ABCC1) as a molecular gate for cellular export of cobalamin. Blood 2010;115:1632-9
   PubMed Web of Science ®Google Scholar
• Fardel O, Le Vee M. Regulation of human hepatic drug transporter expression by pro-inflammatory cytokines. Expert Opin Drug Metab Toxicol 2009;5:1469-81
   PubMed Web of Science ®Google Scholar
• Lecureur V, Ferrec EL, N'Diaye M, ERK-dependent induction of TNFalpha expression by the environmental contaminant benzo(a)pyrene in primary human macrophages. FEBS Lett 2005;579:1904-10
   PubMed Web of Science ®Google Scholar
• Mollenhauer MA, Bradshaw SG, Fair PA, Effects of perfluorooctane sulfonate (PFOS) exposure on markers of inflammation in female B6C3F1 mice. J Environ Sci Health A Tox Hazard Subst Environ Eng 2011;46:97-108
   PubMed Web of Science ®Google Scholar
• Le Vee M, Gripon P, Stieger B, Fardel O. Down-regulation of organic anion transporter expression in human hepatocytes exposed to the proinflammatory cytokine interleukin 1beta. Drug Metab Dispos 2008;36:217-22
   PubMed Web of Science ®Google Scholar
• Stockmann-Juvala H, Alenius H, Savolainen K. Effects of fumonisin B(1) on the expression of cytokines and chemokines in human dendritic cells. Food Chem Toxicol 2008;46:1444-51
   PubMed Web of Science ®Google Scholar
• Le Vee M, Lecureur V, Stieger B, Fardel O. Regulation of drug transporter expression in human hepatocytes exposed to the proinflammatory cytokines tumor necrosis factor-alpha or interleukin-6. Drug Metab Dispos 2009;37:685-93
   PubMed Web of Science ®Google Scholar
• Le Vee M, Jouan E, Moreau A, Fardel O. Regulation of drug transporter mRNA expression by interferon-gamma in primary human hepatocytes. Fundam Clin Pharmacol 2011;25:99-103
   PubMed Web of Science ®Google Scholar
• Morgan ET, Goralski KB, Piquette-Miller M, Regulation of drug-metabolizing enzymes and transporters in infection, inflammation, and cancer. Drug Metab Dispos 2008;36:205-16
   PubMed Web of Science ®Google Scholar
• von Wedel-Parlow M, Wolte P, Galla HJ. Regulation of major efflux transporters under inflammatory conditions at the blood-brain barrier in vitro. J Neurochem 2009;111:111-18
   PubMed Web of Science ®Google Scholar
• Petrovic V, Wang JH, Piquette-Miller M. Effect of endotoxin on the expression of placental drug transporters and glyburide disposition in pregnant rats. Drug Metab Dispos 2008;36:1944-50
   PubMed Web of Science ®Google Scholar
• Forster F, Volz A, Fricker G. Compound profiling for ABCC2 (MRP2) using a fluorescent microplate assay system. Eur J Pharm Biopharm 2008;69:396-403
   PubMed Web of Science ®Google Scholar
• van Breemen RB, Li Y. Caco-2 cell permeability assays to measure drug absorption. Expert Opin Drug Metab Toxicol 2005;1:175-85
   PubMedGoogle Scholar
• Stamatelos SK, Brinkerhoff CJ, Isukapalli SS, Georgopoulos PG. Mathematical model of uptake and metabolism of arsenic(III) in human hepatocytes - Incorporation of cellular antioxidant response and threshold-dependent behavior. BMC Syst Biol 2011;5:16
   PubMedGoogle Scholar
• Dix DJ, Houck KA, Martin MT, The ToxCast program for prioritizing toxicity testing of environmental chemicals. Toxicol Sci 2007;95:5-12
   PubMed Web of Science ®Google Scholar
• Rotroff DM, Beam AL, Dix DJ, Xenobiotic-metabolizing enzyme and transporter gene expression in primary cultures of human hepatocytes modulated by ToxCast chemicals. J Toxicol Environ Health B Crit Rev 2010;13:329-46
   PubMed Web of Science ®Google Scholar
• Kroetz DL, Yee SW, Giacomini KM. The pharmacogenomics of membrane transporters project: research at the interface of genomics and transporter pharmacology. Clin Pharmacol Ther 2010;87:109-16
   PubMed Web of Science ®Google Scholar
• Hodgson E, Rose RL. Human metabolic interactions of environmental chemicals. J Biochem Mol Toxicol 2007;21:182-6
   PubMed Web of Science ®Google Scholar